Irwin A. Heyman

cis-Dichlorodiammineplatinum(II) (NSC-119 875): Preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice

U. Schaeppi, Irwin A. Heyman, Robert W. Fleischman et al. · Toxicology and Applied Pharmacology · 1973 · 132 citations

Preclinical Drug Evaluation, Intravenous Injection, Pharmacology +8

Inhalation, parenteral and oral LD50 values of Δ9-tetrahydrocannabinol in Fischer rats

Harris Rosenkrantz, Irwin A. Heyman, Monique C. Braude · Toxicology and Applied Pharmacology · 1974 · 46 citations

Cannabis Use, Oral Ld50 Values, Health Sciences +9

Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery

Wei Bu, Tsutomu Akama, Sanjay Chanda et al. · Journal of Pharmaceutical and Biomedical Analysis · 2012 · 27 citations

Vivo Rat Metabolites, Biochemistry, Medicine +6

Differential neurochemistry and temporal pattern in rats treated orally with Δ9-tetrahydrocannabinol for periods up to six months

Yugal K. Luthra, Harris Rosenkrantz, Irwin A. Heyman et al. · Toxicology and Applied Pharmacology · 1975 · 26 citations

Cannabis Use, Psychoactive Drug, Molecular Neuroscience +14

Hemolysis study of aqueous polyethylene glycol 400, propylene glycol and ethanol combinations in vivo and in vitro.

Farrel L. Fort, Irwin A. Heyman, J. W. Kesterson · PubMed · 1984 · 20 citations

Biomanufacturing, Urology, Engineering +14